# OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

Save this PDF as:

Size: px
Start display at page:

Download "OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose"

## Transcription

1 OPIOID CONVERSIONS 1. Converting Short acting Long Acting (IR SR) when pain is well controlled *Use for : CHRONIC pain Pts on scheduled IR opioids pain that recurs before the next dose PP: Can use equianalgesic dosing when using same drug Avoid combination agents if you re at this step Bowel regimen, bowel regimen, bowel regimen Instructions: 1. Calculate how many mg of opioid pt is using in 24 hrs convert that amt to long acting Opioid (SR) 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose Case1: Mr. Smith is a 58 year old AAM with chronic bone pain from metastatic prostate CA. He was prescribed Percocet (5/325) in the ER 2 weeks ago and is now in your clinic for f/u. Pain is well controlled on current meds, but tends to recur ~ 1 hr before the next dose. He is taking 2 Percocet every 4 hrs around the clock, even at night. 10mg oxycodone 6 times/day = 60mg oxycodone in 24 hrs Equivalent SR Oxycodone = Oxycontin 30mg q12h Add opioid rescue dose 10% of 60mg = 6mg 20% of 60mg = 12mg ANSWER: Oxycontin 30mg q12h with Oxycodone 5 10 mg q4h prn 2. Converting Short acting Long acting (IR SR) at a higher dose *Use for: Chronic pain unrelieved/ partially relieved by IR meds Instructions: 1. Calculate how many mg of opioid pt is using in 24 hrs convert to long acting opioid 2. Increase long acting opioid by 50% 3. Round up or down based on what pill form is available 4. Adjust rescue dose [10 20% new daily dose] 1

2 Case 2: Same case as above Mr. Smith Pain partially relieved (9/10 6/10) with 2 percocet q4 hrs round the clock 10mg oxycodone 6 times/day = 60mg oxycodone in 24 hrs *Increase oxycodone by 50% [(60 mg + (60mg X50%)] = 60mg + 30 mg = 90 mg oxycodone/day Oxycontin 45mg q 12hr Check pill availability would give Oxycontin 40mg q12h Rescue dose: 10% 80mg = 8 mg 20% 80mg = 16mg ANSWER: Oxycontin 40mg q12h with Oxycodone 10 15mg q4h prn 3. Using rescue doses to increase sustained release opioid PP: Can safely escalate opioid dose in pt with constant pain after pt has been taking SR preparation for hrs Ask pt to record all rescue doses he takes If the total amount of drug taken as a rescue dose is more than 25% of the total SR dose, increase the SR dose by the amount in the rescue doses Case 3: Mr. Smith returns to clinic 2 weeks later. He is taking Oxycontin 40mg q12h and Oxycodone 10mg q4h prn. He reports that he is consistently taking 4 oxycodone/day for breakthrough pain. Total oxycodone /day = 80mg (SR)+ 40mg (IR) = 120 mg oxycodone/day New Oxycontin dose 60mg q12h Rescue dose 10% of 120mg = 12mg 20% of 120mg = 24 mg ANSWER: Oxycontin 60mg q12h with mg oxycodone q4h prn 2

3 SMALL GROUPS Ms. X is a 60 yo WF with chronic RA pain has failed all non opioid pain regimens. You started her on Morphine sulfate 15 mg IR q3h prn, which is controlling her pain and improving her function. She takes the MS IR 8 times/day, around the clock. You want to start her on a sustained release morphine preparation with immediate release morphine for breakthrough pain. Ms. Y is a 35 yo HF with a newly diagnosed soft tissue sarcoma that was resected 3 months ago. She continues to have 8/10 pain despite taking oxycodone 20mg five times/day. What dose of oxycontin and oxycodone IR do you want to start? Mr. Z is a 45 yo WM with a h/o multiple back surgeries, herniated discs, and spinal stenosis after a construction accident 6 years ago. He is currently taking MS Contin 30mg q12h with MS IR 15mg q4h prn pain. He reports pain is well controlled, with improved function and is back at work at a desk job. He takes 4 MS IR tabs/day for breakthrough pain. How would you adjust his MS Contin and MS IR? CHANGING OPIOID AGENTS Use for: Pt s having intolerable side effects on one opioid; cost or delivery method may necessitate changing opioids PP: There is incomplete cross tolerance between different opioids, but the exact amount will differ, thus, equianalgesic tables are only approximations. Depending on age, prior side effects, etc, most experts recommend starting a new opioid at ½ 2/3 of the calculated equianalgesic dose. Instructions: 1. Calculate the 24 hr current opioid dose 2. Use the equianalgesic ratio to calculate new opioid dose 3. Reduce dose by ½ 2/3 for cross tolerance take individual patient into account 3

4 Mrs. T is a 40 yo AAF with a h/o multiple myeloma whose chronic bone pain is well controlled on Oxycontin 80mg q12h with only an occasional Oxycodone 30mg q4h for breakthrough. Her pharmacy is no longer carrying oxycontin because of recent break ins. You want to convert her to MS Contin with MS IR for breakthrough. Current 24 hr opioid dose = 160mg oxycodone/day Po morphine = po oxycodone 160mg oxycodone = 160mg morphine 2/3 (160mg morphine) ~= 106 mg New morphine dose (taking into account pill availability) = 45mg q12h MS Contin Breakthrough dose 10% 90mg = 9 mg, 20% 90mg = 18mg ANSWER: 45mg MS Contin q12h with 15 mg MS IR q4h for breakthrough Mr. X is a 80yo WM with a h/o chronic abdominal pain after multiple abdominal surgeries for colon cancer. His pain is well controlled on MS contin 100mg q12h with MS IR 20mg q2h prn (which he takes 5X/day). He is admitted to the hospital with a new L MCA CVA with mild deficits. He is having difficulty swallowing his pills and wants to try a Fentanyl patch. What dose do you choose? Total morphine/day = 200mg morphine (SR) + 100mg morphine (IR) = 300mg po morphine/day 25mcg/hr fentanyl patch = 1mg/hr IV morphine 25mcg/hr fentanyl patch = 75 mg po morphine/day 300mg po morphine/day X [25mcg/hr fentanyl patch] = 100mcg/hr fentanyl patch [ 75 mg po morphine/day] Reduce for cross tolerance ½ ( 100mcg/hr fentanyl patch) = 50mcg/hr fentanyl patch Answer: 50 mcg/hr Fentanyl patch Breakthrough with MS IR can use same breakthrough dose as before (change form to liquid so pt can swallow) Mr. Z is a 55 yo AAM with intermittent pain in knees from OA. He currently takes MS IR 30mg q4h prn which helps his pain. However, he complains of cloudy thinking at this dose. You try to decrease the dose, which improves the side effect, but does nothing for the pain. You are considering opioid rotation with Dilaudid. What is his new prescription? 4 5 mg po morphine = 1mg po dilaudid 30mg po morphine X [1mg po dilaudid]= 6 mg po dilaudid [5mg po morphine] Reduce for cross tolerance 2/3 = 4mg po dilaudid Answer: 4mg po dilaudid q4h prn 4

7 4. CHANGING OPIOID ROUTE: same drug Use for: po IV : Pt who needs to be NPO; clinical situation that requires rapid titration IV po: calculating home dose of opioids/discharge planning PP: If pt is on a long acting opioid DO NOT just stop it if pt unable to take po, start parenteral basal rate Ex. Ms. T is a 60 yo WF with MM who is taking MS Contin 60mg q12h with an occasional MS IR for breakthrough. She is admitted after a pathologic fracture of her humerus and is NPO for surgery. What IV dose of morphine do you want to start her on? Calculate morphine in 24 hrs = 60mg q12h = 120mg po morphine/24 hrs 3mg po morphine = 1mg IV morphine 120mg po morphine X (1mg IV morphine/3mg po morphine) = 40mg IVmorphine in 24 hrs = 1.6mg/hr IV morphine Mr. M is a 55 yo WM on 20mg po methadone q8h for his chronic abdominal pain from a soft tissue sarcoma. He is admitted with intractable N/V. What do you do with his methadone? 2mg po methadone = 1mg IV methadone Just change route Answer: 10mg IV Methadone q8h 5. CHANGING OPIOID ROUTE: different drug PP: Same rules apply use morphine to calculate equianalgesic dose; decrease new dose by ½ 2/3 for cross tolerance Ex. Mr. A is a 66 yo AAM with chronic back pain from multiple surgeries. He is on Oxycontin 120mg q12h with an occasional oxycodone for breakthrough. He is admitted for a laminectomy. You are the medicine consult for preop and the surgical team wants to start a dilaudid PCA. What basal would you recommend for when pt is NPO? Oxycontin 120mg q12h = 240mg oxycodone/24 hrs = 240mg po morphine/24 hrs = 80mg IV morphine/24 hrs 80mg IV morphine/24 hrs X (1 mg IV dilaudid/ 5mg IV morphine) = 16mg IV dilaudid/24 hrs = 0.67 mg IV dilaudid/hr Reduce for cross tolerance (2/3 X 0.67) = 0.4mg IV dilaudid/hr 7

8 Small Groups: Miss D is a 25 yo AAF with sickle cell anemia who comes to the ER in crisis. She is dehydrated, complains of N/V X 2 days, and is unable to keep any food (or medication) down. According to the pt and the Red Book, she usually takes 90 MS IR q1hr prn for a typical crisis. You would like to give her IV dilaudid prn. What dose to you choose? Ms. P is a 54 yo WF with breast ca with progressive bony mets. She is admitted to N4N for pain control and is placed on a dilaudid PCA to see how much opioid she requires. After looking at the pump history, she has required 60mg IV dilaudid in the last 24 hrs. You would like to start methadone, what dose do you choose? 8

9 Morphine Sulfate IR Morphine Sulfate ER (MS Contin) Oxycodone IR Oxycondone SR (Oxycontin) Dilaudid (hydromorphone) Fentanyl patch Methadone 15 mg, 30 mg tabs; 10mg/ml, 20mg/ml solution 15mg, 30mg, 60mg, 100mg, 200mg tabs 5 mg 10mg, 20mg, 40mg, 80mg, 160mg 2 mg, 4mg, 8 mg 12 mcg/hr, 25 mcg/hr, 50mcg/hr, 75 mcg/hr, 100mcg/hr 5 mg, 10mg, 40mg, 10mg/5ml solution, 5mg/5ml solution RATIOS morphine PO = oxycodone PO 1mg IV morphine = 3 mg PO morphine 1mg/hr IV morphine (= 72mg po morphine/day) = 25 mcg/hr Fentanyl patch 1mg IV morphine = 10 mcg IV fentanyl 100mcg fentanyl lollipop = 1mg IV morphine 5 mg po morphine = 1mg po dilaudid 5mg IV morphine = 1mg IV dilaudid 1 mg IV dilaudid = 4 5 mg po dilaudid 10mg PO morphine = 1mg PO methadone (average) 20 mg po morphine = 1 mg po methadone (when >1000mg MS in 24 hrs) IV = SQ (morphine and dilaudid) 100mg IV morphine = 10mg epidural morphine = 1mg intrathecal morphine 9

### OPIOIDS CONVERSION GUIDELINES 2007

Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating

### Welcome to the Internal Medicine Intern Teaching Conference Series

Welcome to the Internal Medicine Intern Teaching Conference Series Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care mhagman@uw.edu pager 206-540-9725 Intern Teaching

### AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less)

AGS PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less) THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals. Leading change. Improving care for older adults. CASE PRESENTATION 46-year-old

### Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin

Cancer Pain Role Model Program Case Studies and Faculty Guides Wisconsin Cancer Pain Initiative Madison, Wisconsin Developed by: David Weissman, MD June L. Dahl, PhD WISCONSIN CANCER PAIN INITIATIVE CANCER

### 1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain

Pain Management 1 Chapter 34. Pain Management, Self-Assessment Questions 1. Which of the following would NOT be an appropriate choice for postoperative pain management in a patient dependent on opioids?

### Education Program for Prescribers and Pharmacists

Transmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists Products Covered Under This Program Abstral (fentanyl)

### Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,

### Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION

Pain Management Case Studies Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION 3rd Edition David E. Weissman, MD Director, Palliative Care Program Medical College of Wisconsin

### Opioid toxicity and alternative opioids. Palliative care fixed resource session

Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher

### GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323

### How to take your Opioid Pain Medication

How to take your Opioid Pain Medication Today your doctor gave you a prescription for medication to help relieve your pain. The pain medication is called an opioid or narcotic. Taking pain medication,

### Pain Management in Palliative and Hospice Care

Pain Management in Palliative and Hospice Care Donna Butler, MSN, ANP-BC, OCN, ACHPN, FAAPM Current Status of Pain Cancer patients at EOL- 54% have pain AIDS with prognosis < 6mons- intense pain Less research

### Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist

Case Studies: Acute pain management in patients with opioid addiction Shannon Levesque, PharmD Clinical Pharmacist Disclosure I have no financial relationships with industry to disclose Objectives Misconceptions

### Opioids in Palliative Care- Patient Information Manual

Version 2.0 with MST example Introduction The following pages explain what opioids are and what we think you may want to know about them. There is quite a lot of information here, most of it is based on

### Pharmaceutical care of people requiring palliative care Course activities

Pharmaceutical care of people requiring palliative care Course activities Case Study 1 Mrs Green, a 70 year-old lady, has metastatic carcinoma of the breast (breast cancer with spread to other areas).

### Welcome to the Internal Medicine Intern Teaching Course

Welcome to the Internal Medicine Intern Teaching Course Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care mhagman@u.washington.edu pager 206-540-9725 Intern Teaching

### CASE STUDIES - HOME HEALTH

WISCONSIN CANCER PAIN INITIATIVE CASE STUDIES - HOME HEALTH CASE STUDIES AND FACULTY GUIDE Table of Contents Case 1...1 Case 2...1 Case 3...2 Case 4...2 Case 5...3 Case 1: Faculty Guide...4 Case 2: Faculty

### The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline

### Nurses Self Paced Learning Module on Pain Management

Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa

### Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

Pain Control Aims General principles of pain control Basic pharmacokinetics Case history demo Opioids renal failure John Welsh 8/4/2010 Pain Control Morphine is gold standard treatment for moderate to

### The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential

### Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

### WITHDRAWAL OF ANALGESIA AND SEDATION

WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses

### Chronic Pain Management Protocol

Chronic Pain Management Protocol (Pain lasting >90 days, excluding pain due to malignancy or at the end of life) Prior to initiating opioid medications for a chronic problem, at transition from acute pain

### POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped

### MUSC Opioid Analgesic Comparison Chart

MUSC Opioid Analgesic Comparison Chart Approved by the Pharmacy and Therapeutics Committee (February 2006, November 2009, March 2010, December 2011) Prepared by the MUSC Department of Pharmacy Services

### Getting the best result from Opioid medicine. in the management of chronic pain

Getting the best result from Opioid medicine in the management of chronic pain Your doctor has prescribed you opioid medicine to help you manage your chronic pain. This patient information leaflet gives

### Visit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options

In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.

### History of Malignant Pain: Treatment with Opioids. Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients

History of Malignant Pain: Treatment with Opioids Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients March 5-6, 5 2007 Some of the Questions that Must be Answered

### FACTSHEET 6 ON PALLIATIVE CARE PRINCIPLES OF PAIN CONTROL 1: OPIOID ANALGESICS

FACTSHEET 6 ON PALLIATIVE CARE PRINCIPLES OF PAIN CONTROL 1: OPIOID ANALGESICS Pain remains the most feared symptom among cancer patients. Many patients with non-malignant, life-threatening disease also

### Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)

Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently

### Postoperative Pain Management in Children

Postoperative Pain Management in Children Franklyn Cladis MD The Children s Hospital of Pittsburgh Department of Anesthesiology University of Pittsburgh Objectives Describe the use of opioids for postop

### A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation

A Healthesystems Clinical Analysis Insidious Incrementalism of Opioid Use in Workers Compensation Prescription opioid use in the United States has grown significantly over the past 20 years. In 1991, there

### Principles of Highly Effective Pain Managers

Principles of Highly Effective Pain Managers This pocket-size guide presents important principles of pharmacologic pain management and highly effective ways for the clinician to put these principles into

### Opioid Conversion Ratios - Guide to Practice 2013

Opioid s - Guide to Practice 2013 Released 1 st October 2013 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the Eastern

### Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment I ve had breast cancer treatment, and now I m having pain. Does this mean the cancer

### Abstral Prescriber and Pharmacist Guide

Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of

### Basic End of Life Drugs for Qualified Nurses

Basic End of Life Drugs for Qualified Nurses (Please note that this booklet is intended as a training resource and therefore the information contained within it should not replace the medical advice of

### Review of Pharmacological Pain Management

Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization

### WHO Analgesic Ladder. + non opioid. Step 2. Mild to Moderate Pain Weak Opioid: Codeine, Dihydrocodeine, Tramadol

Pain Management This guidance covers: WHO Analgesic Ladder Reducing dosing errors with opioids Opioid toxicity General Pain Management Acute General Pain Management Postoperative (excluding obstetrics)

### Narcotic drugs used for pain treatment Version 4.3

Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the

### PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering

### Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

Opioid s - Guide to Practice 2013 Updated as Version 2 - November 2014 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the

### Richard C. Dart, MD, PhD Denver Health & Hospital Authority Professor, University of Colorado School of Medicine

Richard C. Dart, MD, PhD Denver Health & Hospital Authority Professor, University of Colorado School of Medicine Goal: Minimize abuse and diversion (MAD) while providing pain control for patients. A claim

### A Guide to pain relief medicines For patients receiving Palliative Care

A Guide to pain relief medicines For patients receiving Palliative Care 1 Which pain medicines are you taking? Contents Page No. Amitriptyline 8 Codeine 9 Co-codamol 10 Co-dydramol 11 Diclofenac (Voltarol

### Care Guide: Cancer Pain

Care Guide: Cancer Pain Key Points: Cancer Pain Specific Pain Problems 1. Pain is defined as an independent and emotional experience associated with actual or potential tissue damage or described in terms

Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.

### New England Pediatric Sickle Cell Consortium

New England Pediatric Sickle Cell Consortium Management of Acute Pain in Pediatric Patients with Sickle Cell Disease (Vaso-Occlusive Episodes) Disclaimer Statement: Hospital clinical pathways are designed

### Transitioning Chronic Pain Patients Out of the Hospital. Rosemary Quirk, MD, DTMH ACP, November 7, 2014

Transitioning Chronic Pain Patients Out of the Hospital Rosemary Quirk, MD, DTMH ACP, November 7, 2014 Patients rate baseline chronic pain between 4/10-8/10 on clinic surveys This fact should fundamentally

### Patient information. Using strong Opioids to control your pain

Patient information Using strong Opioids to control your pain Published: April 2013. Date for review: April 2016 Introduction This leaflet explains what strong opioids (pronounced oh-pee-oyds) e are and

### Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel

### Transdermal and Parenteral Fentanyl Dosage Calculations and Conversions

Transdermal and Parenteral Fentanyl Dosage Calculations and Conversions Chapter 5 Objectives After reading this chapter and completing all practice problems, the participant will be able to: 1. Describe

### HERE S THE CASE: A 59-year-old woman notes

THE ART OF ONCOLOGY: WHEN THE TUMOR IS NOT THE TARGET Opioid Rotation in the Management of Refractory Cancer Pain By Rose Anne Indelicato and Russell K. Portenoy HERE S THE CASE: A 59-year-old woman notes

### Pain management. The WHO analgesic ladder

Pain management Successful treatment requires an accurate diagnosis of the cause and a rational approach to therapy. Most pains arise by stimulation of nociceptive nerve endings; the characteristics may

### SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC

### Prescribing for end of life care Dr Andrew Williams Associate Specialist in Palliative Medicine 3 rd October 2012

Prescribing for end of life care Dr Andrew Williams Associate Specialist in Palliative Medicine 3 rd October 2012 objective Illustrate why access to end of life drugs is important Give some guidance on

### Blueprint for Prescriber Continuing Education Program

CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting

### Opioid Conversion Ratios - Guide to Practice 2010

Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. 2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that

### Using strong painkillers for cancer pain

Using strong painkillers for cancer pain This information is an extract from the booklet Controlling cancer pain. You may find the full booklet helpful. We can send you a copy free see page 8. Contents

### Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

Update in Anaesthesia Acute pain management for opioid tolerant patients Simon Marshall and Mark Jackson* *Correspondence email: mark.jackson@rdeft.nhs.uk INTRODUCTION Opioid tolerance is usually encountered

### Policy for the issue of permits to prescribe Schedule 8 poisons

Policy for the issue of permits to prescribe Schedule 8 poisons May 2011 Introduction The Victorian Drugs, Poisons and Controlled Substances (DPCS) legislation sets out certain circumstances when a medical

### SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses

### PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY

AN EXAMINATION OF KNOWLEDGE IN: PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY (EPERC TEST #1) 40 QUESTIONS; MULTIPLE CHOICE; SINGLE-BEST ANSWER Supplied by: End of Life Physician Education

### Objectives. Mechanism-Based Therapy. The Approach to Nausea, Vomiting, and Pain at The End of Life

The Approach to Nausea, Vomiting, and Pain at The End of Life Thomas R. DeGregory D.O. CMD Hospice and Palliative Care Assessment Pathophysiology Treatment Objectives Mechanism-Based Therapy 1. Determine

### Considerations when Using Controlled Substances to Treat Chronic Pain

Considerations when Using Controlled Substances to Treat Chronic Pain By Mary-Beth F. Plum, Pharm.D. Impact of Chronic Pain Acute pain is the body s response to environmental dangers, and it helps protect

### Safely Discontinuing Opioid Analgesics

www.pain-topics.com Safely Discontinuing Opioid Analgesics Author: Editor: Medical Reviewer: Lee A. Kral, PharmD, BCPS Stewart B. Leavitt, MA, PhD Jeffrey Fudin, BS, PharmD, DAAPM Release Date: March 2006

### 10 MG OXYCODONE WITHDRAWAL ZIJA NEW YEAR NEW YOU KIT

10 MG OXYCODONE WITHDRAWAL ZIJA NEW YEAR NEW YOU KIT 10 Mg Oxycodone Withdrawal Zija New Year New You Kit how much is oxycodone per mg why does oxycodone make u itch 2 cold water extraction oxycodone iv

### Management of Patients with Narcotic Bowel Syndrome(1)

Management of Patients with Narcotic Bowel Syndrome(1) Ademola Aderoju MD, Jacob Kurlander MD, Christina Davis, Patrick Barrett MD, Douglas A. Drossman MD Patients on chronic narcotics who have been diagnosed

### Appendix 1 - Anticipatory Medications for End of Life Patients Doses must be proportional to the current analgesic medication

Appendix 1 - Anticipatory Medications for End of Life Patients Doses must be proportional to the current analgesic medication For patients on Methadone or Ketamine, or to convert from other strong opioids,

### Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate

### Pharmacotherapy: opioids, NSAIDs, adjuvants, and analgesic e...

1. : opioids, NSAIDs, adjuvants, and analgesic e... 2. of Pain Page - 1 3. Mechanisms of Pain and Medication Activity Sites 4. Classes of analgesics Page - 2 5. Severity: WHO analgesic ladder 6. Pain Source

### Palliative Medicine, Pain Management, and Hospice. Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine

Palliative Medicine, Pain Management, and Hospice Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine Pall-i- What??? Objectives: Provide information about Palliative Medicine

### Cancer Pain. Treatment Guidelines for Patients

Cancer Pain Treatment Guidelines for Patients Version II/ August 2005 Current NCCN Treatment Guidelines for Patients Advanced Cancer and Palliative Care Treatment Guidelines for Patients (also available

### Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013

Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013 Access to palliative care drugs out of hours Agreement set up with local community pharmacy s to hold stock of commonly prescribed

### Opioids, Benzos, and Tapering, Oh My! Disclosures

Opioids, Benzos, and Tapering, Oh My! Melissa B. Weimer, DO, MCR March 10, 2016 Disclosures Dr. Weimer is a paid consultant for INFORMed and a speaker for IMPACT education. Dr. Weimer is the medical director

### Pain Management. Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010

Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010 Pain Management Learning Objectives- Identify most common barriers to effective treatment of pain. Describe principles of effective

### Anticipatory Medications for End of Life Patients Doses must be proportional to the current analgesic medication

Anticipatory Medications for End of Life Patients Doses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

### Ambulatory Surgery Center Coding and Payment Guide 2015

Targeted Drug Delivery Ambulatory Surgery Center Coding and Payment Guide 2015 Flowonix Medical has compiled this coding information for your convenience. This information is gathered from third party

### Pain is a symptom people associate with a malignant illness and is common in non malignant disease.

HAWKE S BAY DISTRICT HEALTH BOARD Manual: Clinical Guidelines Manual CRANFORD HOSPICE Doc No: HBDHB/IVTG/139 Issue Date: Review Date: 3 yearly Approved: Cranford Hospice Medical Pain in the Palliative

### CORONER S REPORT REPORT

CORONER S REPORT 26 THE CORONER HAS RECOMMENDED THAT THE ONTARIO COLLEGE OF PHARMACISTS EDUCATE CLINICIANS ON THE DEFINITION OF OPIOID TOLERANCE, AND REVIEW THE PATIENT CONDITIONS AND COMORBIDITIES THAT

### Pain Medication Taper Regimen Time frame to taper off 30-60 days

Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more

### Options in Pain Management Alice Looney ANP-C Kreisberg Family Pain Management Center Saint Luke s Cornwall Hospital

Options in Pain Management Alice Looney ANP-C Kreisberg Family Pain Management Center Saint Luke s Cornwall Hospital To decrease pain To improve lifestyle To decrease the need for drugs (including narcotics

### West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline

West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline This guidance forms part of the West of Scotland Efficiency and Productivity Workstream, Acute Prescribing Group. Clinicians from

### Pain Management & Resources Survivorship Forum June Pippa Hawley BCCA Pain & Symptom Management/Palliative Care

Pain Management & Resources Survivorship Forum June 2015 Pippa Hawley BCCA Pain & Symptom Management/Palliative Care What Is Pain? An unpleasant sensory and emotional experience associated with actual

### Pain Medication What you need to know about opioid analgesics

Pain Medication What you need to know about opioid analgesics Pain Medication What you need to know about opioid analgesics Developed for the McGill University Health Centre (MUHC) by the Task Force for

### m y f o u n d a t i o n i n f o s h e e t

Pain and Myeloma m y f o u n d a t i o n i n f o s h e e t Pain is the most common symptom of myeloma and can greatly affect all areas of your life, especially if it is untreated or poorly managed. This

### Pain and Symptom Management in the Pancreatic Cancer Patient. Objectives:

Pain and Symptom Management in the Pancreatic Cancer Patient Michael D. Harrington, M.D. Division of Geriatrics and Palliative Care MetroHealth Medical Center April 25, 2012 Objectives: Understand palliative

### Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs

Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility Nancy Lamb RPh Good Day Pharmacy DEA- Drug Enforcement Administration This is not the State Health Department

### CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

### Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years \$560-635

### Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions

### Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu Barriers to effective pain relief Freedom from pain is a basic human right -WHO Pain is whatever the experiencing person says it is and exists

### Pain and problem drug use

Pain and problem drug use Information for patients Prepared by the British Pain Society in consultation with the Royal College of Psychiatrists, the Royal College of General Practitioners and the Advisory

### MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

### Overview of painkillers for cancer pain

Overview of painkillers for cancer pain This information is an extract from the booklet Controlling cancer pain. You may find the full booklet helpful. We can send you a copy free see page 9. Painkillers

### SCOPING DOCUMENT FOR WHO Treatment Guidelines on chronic non-malignant pain in adults

SCOPING DOCUMENT FOR WHO Treatment Guidelines on chronic non-malignant pain in adults BACKGROUND The initiative to develop these guidelines emerged from the findings of the Delphi study conducted (1) for

### KEY CONCEPTS IN ACUTE PAIN MANAGEMENT. John Penning MD FRCPC Director Acute Pain Service

KEY CONCEPTS IN ACUTE PAIN MANAGEMENT John Penning MD FRCPC Director Acute Pain Service Objectives Why is acute pain management important? Clinical concepts not readily found in texts COX-inhibitors, the